In Part II of an exclusive interview with GEN Edge, O’Neill and Mullen discuss Editas’ search for a new chief medical officer to succeed Lisa Michaels, MD, who was immediately terminated February 7 without explanation; which programs Editas will seek to partner; Editas’ response to an analyst who questioned how the company will assess the success of EDIT-101; and the company’s workforce expansion plans . . .
Editas’ Current and Future CEOs Discuss CMO Search, EDIT-101, and Growth
In Part II of an exclusive interview with GEN Edge, Editas CEO Jim Mullen and his designated successor , Gilmore O’Neill, discuss what Editas is seeking in a chief medical officer, and how its workforce is expected to expand.
[Source: Natali_mis/Getty Images]